SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001367920-22-000030
Filing Date
2022-04-26
Accepted
2022-04-26 07:06:50
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A a2022notice.htm DEFA14A 11489
2 noticeprooffinal_pagex1.jpg GRAPHIC 521112
3 noticeprooffinal_pagex2.jpg GRAPHIC 381421
  Complete submission text file 0001367920-22-000030.txt   1255203
Mailing Address 65 HAYDEN AVENUE SUITE 3000N LEXINGTON MA 02421
Business Address 65 HAYDEN AVENUE SUITE 3000N LEXINGTON MA 02421 781-860-0045
CONCERT PHARMACEUTICALS, INC. (Filer) CIK: 0001367920 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36310 | Film No.: 22851736
SIC: 2834 Pharmaceutical Preparations